EUVIMEDEUVIMED entdecken
Crossref

Tumor Anti-angiogenesis: Nano-Arsenal will Kill the Crab

Feroz Alam, Kafil Akhtar, Veena Maheshwari, Mahboob Hasan

Future Health · 2023

DOI: 10.25259/fh_20230101_79 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Health, 2023. Verfasst von Feroz Alam und 3 weiteren Autor:innen. Die Arbeit nennt 87 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Angiogenesis: the process of developing new blood vessels from the pre-existing ones is a very crucial process in tumor formation, growth, progression and metastasis. The central role of angiogenesis in tumor growth and progression compels targeting tumor vasculature as a therapeutic mean. Nanoparticles have revolutionized the domain of cancer therapeutics, molecularly targeted anti-cancer drugs represents one of the most significant recent advances in clinical oncology. Various types of nano-drug complexes which targets tumor vasculature preferentially, are being increasingly tested for optimal therapeutic efficacy and minimal side-effects. Here, we review some of these anti-angiogenic nano-drug complexes.

Zitieren

APA

Alam, F., Akhtar, K., Maheshwari, V., & Hasan, M. (2023). Tumor Anti-angiogenesis: Nano-Arsenal will Kill the Crab. Future Health. https://doi.org/10.25259/fh_20230101_79

Vancouver

Alam F, Akhtar K, Maheshwari V, Hasan M. Tumor Anti-angiogenesis: Nano-Arsenal will Kill the Crab. Future Health. 2023. doi:10.25259/fh_20230101_79

BibTeX
@article{Alam2023,
  author = {Alam, Feroz and Akhtar, Kafil and Maheshwari, Veena and Hasan, Mahboob},
  title = {Tumor Anti-angiogenesis: Nano-Arsenal will Kill the Crab},
  journal = {Future Health},
  year = {2023},
  doi = {10.25259/fh_20230101_79}
}
Kostenlos starten →